
Mitochondria and Cancer
From Basic Science to Clinical Applications – Understanding Pathogenesis, Therapy Resistance, and Disease Relapse
- 1st Edition - March 1, 2026
- Editors: Farhad Taghizadeh-Hesary, Sumel Ashique, Babak Behnam, Maria Vliora
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 4 0 5 3 5 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 4 0 5 3 6 - 5
Mitochondria and Cancer: From Basic Science to Clinical Applications – Understanding Pathogenesis, Therapy Resistance, and Disease Relapse is an essential reference for understa… Read more
Purchase options

- Combines fundamental scientific knowledge with clinical relevance, covering a wide array of topics from mitochondrial metabolism to innovative therapeutic strategies
- Features unique topics such as applying magnetic fields to target mitochondria, offering cutting-edge approaches to cancer treatment and management
- Includes contributions from experts across different countries and institutions, providing a well-rounded, global view of current research in mitochondrial involvement in cancer
2. Mitochondrial Metabolism and Trafficking in Cancer
3. Mitochondrial Genome and Cancer
4. Mitochondrial-nuclear Crosstalk and Its Role in Cancer
5. Mitochondria and Tumor Microenvironment
6. Mitochondria and Cancer Stem Cells
7. Mitochondria, Exosome, Cancer
8. Mitochondria, Microbiota, Cancer
9. MiRNAs and Their Impacts on Cancer Cell’s Mitochondria
10. Mitochondria and Cancer Prevention
11. Mitochondria and Cancer Diagnosis
12. Mitochondrial Metabolism as a Prognostic Biomarker (Mitochondria and Cancer Progression)
13. Mitochondria, Tumor Microenvironment, and Radioresistance
14. Mitochondria and Resistance to Chemotherapy
15. Mitochondria and Resistance to Targeted Therapies
16. Mitochondria and Resistance to Immunotherapy
17. Mitochondria Enhancing Strategies in Cancer
18. Advances in Targeted Anti-mitochondrial Therapies
19. Applying Magnetic Fields to Target Mitochondria
- Edition: 1
- Published: March 1, 2026
- Language: English
FT
Farhad Taghizadeh-Hesary
Dr. Farhad Taghizadeh-Hesary is an economics and finance associate professor at Tokai University in Japan. He is the co-founder and vice president of the International Society for Energy Transition Studies (ISETS), Editor-in-Chief of the Journal of Environmental Assessment Policy and Management (World Scientific), and associate editor of several academic journals. He has authored over 350 peer-reviewed journal papers and book chapters and edited 25 books by major publishers in various fields, including green finance and sustainability, energy economics, and policy. He was included on Clarivate’s list of Highly Cited Researchers. In 2023, he received the Commendation and Medal for Science and Technology from the Minister of Education, Culture, Sports, Science, and Technology of Japan for his outstanding research achievements. He holds a Ph.D. in economics from Keio University, Japan.
SA
Sumel Ashique
Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & 20 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing 13 books under CRC Press, Taylor & Francis, Springer and Wiley.
BB
Babak Behnam
Dr. Babak Behnam has completed his PhD degree at the University College London (UCL) in Human Genetics. Then he served as postdoctoral research fellow at the University of Michigan School of Medicine and University of Central Florida (UCF). He joined the Undiagnosed Disease Program (UDP) at NIH while doing an American Board of Medical Genetics and Genomic in clinical biochemical laboratory genetics at NHGRI, NIH. He joined NSF International as a clinical research organization. Dr. Behnam has published more than 70 peer-reviewed papers and has nine patents to his name throughout his career; also, has served as an Editorial Board Member of several scientific journals. He has enthusiasm in translational research, neuroscience & neurogenetics, and biochemical & molecular mechanisms utilizing advanced technological improvements in biochemical genetics, genomics, and NGS platforms. Also, he has an experience and interest in clinical research, and regulatory and scientific analysis of clinical trials.
MV